|
|
 |
|
Viewing report
|
|
|
|
Cross Border Alliances in Biopharma Industry - Survey Report on US Companies
CYGNUS Business Consulting & Research, May 2006, Pages: 61
The Biopharmaceutical Industry is escalating in size with the growth in revenues across the globe. Of late, the industry has been seeing a spurt in mergers and acquisitions, collaborations and alliances. The need for increasingly innovative and successful products has been driving the industry to form strategic alliances and partnerships and this has lead to over 2,600 alliances being signed by the top 20 pharmaceutical players in the last two decades. This model of partnering for research and manufacturing activities reduces risk and provides access to new technologies, coupled with advantages of savings in cost and time.
To understand the US biopharmaceutical industrys views on cross-border alliances, a web-based survey was conducted to capture information on the companies, their plans for entering new markets, and for leveraging partnerships and alliances for growth and profitability. The survey questionnaire was completed by respondents from US companies, of whom 66% were key decision makers. Survey parameters included the strategies of the companies for market expansion, in short run as well as medium term, plans for outsourcing and the types of business models preferred for alliances. This report is useful for the companies to understand the perspectives of the US players so as to enable them to formulate the alliance strategies.
Customers who bought this item also bought
Pulmonary Drug Delivery Technologies - Global Strategic Business Report
Biopharmaceuticals Market Trends & Competition
Biopharmaceuticals Market Trends & Competition
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
Human Vaccines - Global Strategic Business Report
Pain Management - Global Strategic Business Report
Cardiovascular Disease Diagnostics - Global Strategic Business Report
Regenerative Medicine - Global Strategic Business Report
Angiogenesis Inhibitors and Stimulators - Global Strategic Business Report
Pharmaceutical Contract Manufacturing - Global Strategic Business Report
|
|
|
|
